-
EP2341076
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2341076
| EP2341076 - Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.04.2015 Database last updated on 02.11.2024 | Most recent event Tooltip | 17.04.2015 | Application deemed to be withdrawn | published on 20.05.2015 [2015/21] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2011/27] | Inventor(s) | 01 /
Bardroff, Michael MorphoSys AG Schietweg 2a 81375 Munchen / DE | 02 /
Edwards, Matthew Novartis Horsham Research Centre Wimblehurst Road Horsham, Sussex RH12 5AB / GB | 03 /
Tur, Mehmet Novartis Pharma AG Am Steinberg 43 52353 Duren / DE | 04 /
Ratsch, Olaf Lochhamer Str, 79 82166 Grafelfing / DE | [2011/27] | Representative(s) | Kassow, Anders, et al Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
| Former [2012/12] | Deriu, Daniela Novartis Pharma AG Patent Department 4002 Basel / CH | ||
| Former [2011/27] | Kassow, Anders Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 10183229.3 | 21.02.2007 | [2011/27] | Priority number, date | GB20060003683 | 23.02.2006 Original published format: GB 0603683 | [2011/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2341076 | Date: | 06.07.2011 | Language: | EN | [2011/27] | Type: | A3 Search report | No.: | EP2341076 | Date: | 24.08.2011 | [2011/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.07.2011 | Classification | IPC: | C07K16/24, A61K39/395, C12N15/13, A61P37/00 | [2011/27] | CPC: |
A61P11/06 (EP);
C07K16/24 (KR,US);
A61K39/395 (KR);
A61P17/00 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
C07K16/244 (EP,US);
C12N15/11 (KR);
A61K2039/505 (EP,US);
C07K2317/21 (EP,US);
C07K2317/55 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/27] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | Thymus-Stromal-Lymphopoietin (TSLP) Antikörper und deren Verwendungen | [2011/27] | English: | Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof | [2011/27] | French: | Anticorps de lymphopoiétines stromales thymiques (TSLP) et utilisations associées | [2011/27] | Examination procedure | 02.02.2012 | Amendment by applicant (claims and/or description) | 24.02.2012 | Examination requested [2012/14] | 27.03.2013 | Despatch of a communication from the examining division (Time limit: M06) | 23.08.2013 | Reply to a communication from the examining division | 19.05.2014 | Despatch of a communication from the examining division (Time limit: M06) | 02.12.2014 | Application deemed to be withdrawn, date of legal effect [2015/21] | 09.01.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/21] | Parent application(s) Tooltip | EP07722882.3 / EP1991583 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20070722882) is 13.01.2009 | Fees paid | Renewal fee | 31.01.2011 | Renewal fee patent year 03 | 31.01.2011 | Renewal fee patent year 04 | 15.02.2011 | Renewal fee patent year 05 | 15.02.2012 | Renewal fee patent year 06 | 28.02.2013 | Renewal fee patent year 07 | 12.02.2014 | Renewal fee patent year 08 | 02.03.2015 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO03065985 (SCHERING CORP [US]) [A] 1-24 * page 7, line 7 - page 8, line 8 * * page 12, line 11 - line 14 * * page 13, line 14 - page 15, line 31 * * claims 1-13,18,21 *; | [A] - SOUMELIS V ET AL, "Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP", NATURE IMMUNOLOGY, NATURE PUBLISHING GROUP,, GB, (200207), vol. 3, no. 7, ISSN 1529-2908, pages 673 - 680, XP002364946 [A] 1-24 * page 674, column L, paragraph 1 * * page 676, column R, paragraphs 2,3 * * page 679, column R, paragraph 2 * * page 680, column L, paragraph 3 * | [AD] - Anti-human TSLP Antibody AF1398, R&D SYSTEMS, INC, (20060215), XP002438641 [AD] 1-24 * the whole document * | [A] - SOUMELIS V ET AL, "Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation", SPRINGER SEMINAR IN IMMUNOPATHOLOGY, SPRINGER VERLAG, DE, (200402), vol. 25, no. 3-4, ISSN 0344-4325, pages 325 - 333, XP002364947 [A] 1-24 * the whole document, especially page 331, second paragraph * DOI: http://dx.doi.org/10.1007/s00281-003-0152-0 | [A] - BROWN MCKAY ET AL, "Tolerance to single, but not multiple, amino acid replacements in antibody V-H CDR2: A means of minimizing B cell wastage from somatic hypermutation?", JOURNAL OF IMMUNOLOGY, (1996), vol. 156, no. 9, ISSN 0022-1767, pages 3285 - 3291, XP002649029 [A] 1-24 * the whole document * |